论文部分内容阅读
Infliximab (IFX) is an anti-tumor necrosis factorchimeric antibody that is effective for treatment ofautoimmune disorders such as Crohn's disease andulcerative colitis (UC). IFX is well tolerated with alow incidence of adverse effects such as infections,s